Kulinska, K.I.; Andrusiewicz, M.; Dera-Szymanowska, A.; Billert, M.; Skrzypski, M.; Szymanowski, K.; Nowak-Markwitz, E.; Kotwicka, M.; Wołuń-Cholewa, M.
Phoenixin as a New Target in the Development of Strategies for Endometriosis Diagnosis and Treatment. Biomedicines 2021, 9, 1427.
https://doi.org/10.3390/biomedicines9101427
AMA Style
Kulinska KI, Andrusiewicz M, Dera-Szymanowska A, Billert M, Skrzypski M, Szymanowski K, Nowak-Markwitz E, Kotwicka M, Wołuń-Cholewa M.
Phoenixin as a New Target in the Development of Strategies for Endometriosis Diagnosis and Treatment. Biomedicines. 2021; 9(10):1427.
https://doi.org/10.3390/biomedicines9101427
Chicago/Turabian Style
Kulinska, Karolina Iwona, Mirosław Andrusiewicz, Anna Dera-Szymanowska, Maria Billert, Marek Skrzypski, Krzysztof Szymanowski, Ewa Nowak-Markwitz, Małgorzata Kotwicka, and Maria Wołuń-Cholewa.
2021. "Phoenixin as a New Target in the Development of Strategies for Endometriosis Diagnosis and Treatment" Biomedicines 9, no. 10: 1427.
https://doi.org/10.3390/biomedicines9101427
APA Style
Kulinska, K. I., Andrusiewicz, M., Dera-Szymanowska, A., Billert, M., Skrzypski, M., Szymanowski, K., Nowak-Markwitz, E., Kotwicka, M., & Wołuń-Cholewa, M.
(2021). Phoenixin as a New Target in the Development of Strategies for Endometriosis Diagnosis and Treatment. Biomedicines, 9(10), 1427.
https://doi.org/10.3390/biomedicines9101427